|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Center MM, Ward E and Thun MJ:
Cancer occurrence. Methods Mol Biol. 471:3–29. 2009. View Article : Google Scholar
|
|
3
|
Nautiyal J, Kanwar SS, Yu Y and Majumdar
AP: Combination of dasatinib and curcumin eliminates
chemo-resistant colon cancer cells. J Mol Signal. 6:72011.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhang N, Yin Y, Xu SJ and Chen WS:
5-Fluorouracil: Mechanisms of resistance and reversal strategies.
Molecules. 13:1551–1569. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jiang WQ, Fu FF, Li YX, Wang WB, Wang HH,
Jiang HP and Teng LS: Molecular biomarkers of colorectal cancer:
Prognostic and predictive tools for clinical practice. J Zhejiang
Univ Sci B. 13:663–675. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Simeone DM: pancreatic cancer stem cells:
Implications for the treatment of pancreatic cancer. Clin Cancer
Res. 14:5646–5648. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Boman BM and Huang E: Human colon cancer
stem cells: A new paradigm in gastrointestinal oncology. J Clin
Oncol. 26:2828–2838. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Vermeulen L, Sprick MR, Kemper K, Stassi G
and Medema JP: Cancer stem cells - old concepts, new insights. Cell
Death Differ. 15:947–958. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shipitsin M and Polyak K: The cancer stem
cell hypothesis: In search of definitions, markers, and relevance.
Lab Invest. 88:459–463. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fabrizi E, di Martino S, Pelacchi F and
Ricci-Vitiani L: Therapeutic implications of colon cancer stem
cells. World J Gastroenterol. 16:3871–3877. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ong CW, Kim LG, Kong HH, Low LY, Iacopetta
B, Soong R and Salto-Tellez M: CD133 expression predicts for
non-response to chemotherapy in colorectal cancer. Mod Pathol.
23:450–457. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Saigusa S, Tanaka K, Toiyama Y, Yokoe T,
Okugawa Y, Kawamoto A, Yasuda H, Morimoto Y, Fujikawa H, Inoue Y,
et al: Immunohistochemical features of CD133 expression:
Association with resistance to chemoradiotherapy in rectal cancer.
Oncol Rep. 24:345–350. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sarkar B, Dosch J and Simeone DM: Cancer
stem cells: A new theory regarding a timeless disease. Chem Rev.
109:3200–3208. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mueller MT, Hermann PC, Witthauer J,
Rubio-Viqueira B, Leicht SF, Huber S, Ellwart JW, Mustafa M,
Bartenstein P, D'Haese JG, et al: Combined targeted treatment to
eliminate tumorigenic cancer stem cells in human pancreatic cancer.
Gastroenterology. 137:1102–1113. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mahmoudi N, de Julián-Ortiz JV, Ciceron L,
Gálvez J, Mazier D, Danis M, Derouin F and García-Domenech R:
Identification of new antimalarial drugs by linear discriminant
analysis and topological virtual screening. J Antimicrob Chemother.
57:489–497. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mitani M, Yamanishi T, Miyazaki Y and
Otake N: Salinomycin effects on mitochondrial ion translocation and
respiration. Antimicrob Agents Chemother. 9:655–660. 1976.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Naujokat C, Fuchs D and Opelz G:
Salinomycin in cancer: A new mission for an old agent. Mol Med Rep.
3:555–559. 2010. View Article : Google Scholar
|
|
18
|
Huczynski A: Salinomycin: A new cancer
drug candidate. Chem Biol Drug Des. 79:235–238. 2012. View Article : Google Scholar
|
|
19
|
Gupta PB, Onder TT, Jiang G, Tao K,
Kuperwasser C, Weinberg RA and Lander ES: Identification of
selective inhibitors of cancer stem cells by high-throughput
screening. Cell. 138:645–659. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang Y: effects of salinomycin on cancer
stem cell in human lung adenocarcinoma A549 cells. Med Chem.
7:106–111. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
|
|
22
|
Tang QL, Zhao ZQ, Li JC, Liang Y, Yin JQ,
Zou CY, Xie XB, Zeng YX, Shen JN, Kang T, et al: Salinomycin
inhibits osteosarcoma by targeting its tumor stem cells. Cancer
Lett. 311:113–121. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Basu D, Montone KT, Wang LP, Gimotty PA,
Hammond R, Diehl JA, Rustgi AK, Lee JT, Rasanen K, Weinstein GS, et
al: Detecting and targeting mesenchymal-like subpopulations within
squamous cell carcinomas. Cell Cycle. 10:2008–2016. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ketola K, Hilvo M, Hyötyläinen T, Vuoristo
A, Ruskeepää AL, Orešič M, Kallioniemi O and Iljin K: Salinomycin
inhibits prostate cancer growth and migration via induction of
oxidative stress. Br J Cancer. 106:99–106. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang GN, Liang Y, Zhou LJ, Chen SP, Chen
G, Zhang TP, Kang T and Zhao YP: Combination of salinomycin and
gemcitabine eliminates pancreatic cancer cells. Cancer Lett.
313:137–144. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kim KY, Yu SN, Lee SY, Chun SS, Choi YL,
Park YM, Song CS, Chatterjee B and Ahn SC: Salinomycin-induced
apoptosis of human prostate cancer cells due to accumulated
reactive oxygen species and mitochondrial membrane depolarization.
Biochem Biophys Res Commun. 413:80–86. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fuchs D, Heinold A, Opelz G, Daniel V and
Naujokat C: Salinomycin induces apoptosis and overcomes apoptosis
resistance in human cancer cells. Biochem Biophys Res Commun.
390:743–749. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Maitland NJ and Collins AT: prostate
cancer stem cells: A new target for therapy. J Clin Oncol.
26:2862–2870. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Dong TT, Zhou HM, Wang LL, Feng B, Lv B
and Zheng MH: Salinomycin selectively targets 'CD133+'
cell subpopulations and decreases malignant traits in colorectal
cancer lines. Ann Surg Oncol. 18:1797–1804. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lee S and Schmitt CA: Chemotherapy
response and resistance. Curr Opin Genet Dev. 13:90–96. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Leibowitz B and Yu J: Mitochondrial
signaling in cell death via the Bcl-2 family. Cancer Biol Ther.
9:417–422. 2010. View Article : Google Scholar : PubMed/NCBI
|
